BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Alcohol
,
Lipitor
,
rs2476601
,
PRKCA
,
cell-cell adhesion
,
Diabetes mellitus
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NY-ESO-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Infection due to Haemophilus
Fetal growth restriction
Disease due to Orthopoxvirus
Mycobacteriosis
Other cancer
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
C-Peptide
Ions
heptanal
triptolide
propionaldehyde
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FDCSP
NUP62
NR3C1
DNMT1
DNMT3B
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Acetylation of Rec8 cohesin complexes regulates reductional chromosome segregation in meiosis.
An acetyltransferase-independent function of Eso1 regulates centromere cohesion.
Cohesin Impedes Heterochromatin Assembly in Fission Yeast Cells Lacking Pds5.
A second Wpl1 anti-cohesion pathway requires dephosphorylation of fission yeast kleisin Rad21 by PP4…
Pds5 promotes cohesin acetylation and stable cohesin-chromosome interaction.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expre…
Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
NY-ESO-1-Specific T-cells in Treating Patients With Advanced NY-ESO-1-Expressing Sarcomas Receiving …
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally …
Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ